# Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex:  Developing Drugs for Treatment :  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/nontuberculous-mycobacterial-pulmonary-disease-caused-by-mycobacterium-avium-complex-developing-drugs-for-treatment-guidance-for-industry/dda15f98-e807-4823-898a-ad26150481d1

> FDA guidance document: Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex:  Developing Drugs for Treatment :  Guidance for Industry. Issue date: September 05, 2023. Get complete insights and analysis.

---

## Details

- Title: Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex:  Developing Drugs for Treatment :  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-09-05
- Last Changed: 2023-09-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-0544">FDA-2021-D-0544</a>

## Related Documents

- [Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/smallpox-variola-virus-infection-developing-drugs-for-treatment-or-prevention-guidance-for-industry/c6eb4d8b-888a-4dc5-bb4d-877f66f968fb)
- [Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/eosinophilic-esophagitis-developing-drugs-for-treatment-guidance-for-industry/e454ac25-939f-4e9c-a8f1-b2613feff0b3)
- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)